Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

474 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pioneering a paradigm shift in asthma management: remission as a treatment goal.
Lommatzsch M, Buhl R, Canonica GW, Ribas CD, Nagase H, Brusselle GG, Jackson DJ, Pavord ID, Korn S, Milger K, Taube C, Virchow JC. Lommatzsch M, et al. Among authors: jackson dj. Lancet Respir Med. 2024 Feb;12(2):96-99. doi: 10.1016/S2213-2600(23)00415-0. Epub 2023 Dec 7. Lancet Respir Med. 2024. PMID: 38071999 No abstract available.
Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial.
Heaney LG, Busby J, Hanratty CE, Djukanovic R, Woodcock A, Walker SM, Hardman TC, Arron JR, Choy DF, Bradding P, Brightling CE, Chaudhuri R, Cowan DC, Mansur AH, Fowler SJ, Niven RM, Howarth PH, Lordan JL, Menzies-Gow A, Harrison TW, Robinson DS, Holweg CTJ, Matthews JG, Pavord ID; investigators for the MRC Refractory Asthma Stratification Programme. Heaney LG, et al. Lancet Respir Med. 2021 Jan;9(1):57-68. doi: 10.1016/S2213-2600(20)30397-0. Epub 2020 Sep 8. Lancet Respir Med. 2021. PMID: 32916135 Free PMC article. Clinical Trial.
Addressing unmet needs in understanding asthma mechanisms: From the European Asthma Research and Innovation Partnership (EARIP) Work Package (WP)2 collaborators.
Edwards MR, Saglani S, Schwarze J, Skevaki C, Smith JA, Ainsworth B, Almond M, Andreakos E, Belvisi MG, Chung KF, Cookson W, Cullinan P, Hawrylowicz C, Lommatzsch M, Jackson D, Lutter R, Marsland B, Moffatt M, Thomas M, Virchow JC, Xanthou G, Edwards J, Walker S, Johnston SL; members of the EARIP WP2 working group. Edwards MR, et al. Eur Respir J. 2017 May 1;49(5):1602448. doi: 10.1183/13993003.02448-2016. Print 2017 May. Eur Respir J. 2017. PMID: 28461300 Free article. Review.
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study.
Jackson DJ, Heaney LG, Humbert M, Kent BD, Shavit A, Hiljemark L, Olinger L, Cohen D, Menzies-Gow A, Korn S; SHAMAL Investigators. Jackson DJ, et al. Lancet. 2024 Jan 20;403(10423):271-281. doi: 10.1016/S0140-6736(23)02284-5. Epub 2023 Dec 7. Lancet. 2024. PMID: 38071986 Free article. Clinical Trial.
Pulmonary Innate Lymphoid Cell Responses during Rhinovirus-induced Asthma Exacerbations In Vivo: A Clinical Trial.
Dhariwal J, Cameron A, Wong E, Paulsen M, Trujillo-Torralbo MB, Del Rosario A, Bakhsoliani E, Kebadze T, Almond M, Farne H, Gogsadze L, Aniscenko J, Rana BMJ, Hansel TT, Jackson DJ, Kon OM, Edwards MR, Solari R, Cousins DJ, Walton RP, Johnston SL; MRC-GSK Strategic Alliance Consortium. Dhariwal J, et al. Among authors: jackson dj. Am J Respir Crit Care Med. 2021 Dec 1;204(11):1259-1273. doi: 10.1164/rccm.202010-3754OC. Am J Respir Crit Care Med. 2021. PMID: 34469272 Free PMC article. Clinical Trial.
Azithromycin for Acute Exacerbations of Asthma : The AZALEA Randomized Clinical Trial.
Johnston SL, Szigeti M, Cross M, Brightling C, Chaudhuri R, Harrison T, Mansur A, Robison L, Sattar Z, Jackson D, Mallia P, Wong E, Corrigan C, Higgins B, Ind P, Singh D, Thomson NC, Ashby D, Chauhan A; AZALEA Trial Team. Johnston SL, et al. JAMA Intern Med. 2016 Nov 1;176(11):1630-1637. doi: 10.1001/jamainternmed.2016.5664. JAMA Intern Med. 2016. PMID: 27653939 Free article. Clinical Trial.
Author Correction: Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19.
Radzikowska U, Eljaszewicz A, Tan G, Stocker N, Heider A, Westermann P, Steiner S, Dreher A, Wawrzyniak P, Rückert B, Rodriguez-Coira J, Zhakparov D, Huang M, Jakiela B, Sanak M, Moniuszko M, O'Mahony L, Jutel M, Kebadze T, Jackson DJ, Edwards MR, Thiel V, Johnston SL, Akdis CA, Sokolowska M. Radzikowska U, et al. Among authors: jackson dj. Nat Commun. 2023 Jun 13;14(1):3493. doi: 10.1038/s41467-023-39275-x. Nat Commun. 2023. PMID: 37311773 Free PMC article. No abstract available.
A randomised, double-blind, placebo-controlled study to evaluate the efficacy of oral azithromycin as a supplement to standard care for adult patients with acute exacerbations of asthma (the AZALEA trial).
Johnston SL, Szigeti M, Cross M, Brightling C, Chaudhuri R, Harrison T, Mansur A, Robison L, Sattar Z, Jackson D, Mallia P, Wong E, Corrigan C, Higgins B, Ind P, Singh D, Thomson N, Ashby D, Chauhan A. Johnston SL, et al. Southampton (UK): NIHR Journals Library; 2016 Oct. Southampton (UK): NIHR Journals Library; 2016 Oct. PMID: 27809421 Free Books & Documents. Review.
Characteristics of patients in platform C19, a COVID-19 research database combining primary care electronic health record and patient reported information.
Stanley B, Davis A, Jones R, Julious S, Ryan D, Jackson D, Halpin D, Pinnock H, Quint J, Khunti K, Heaney L, Oliver P, Siddiqui S, Kemppinen A, Appiagyei F, Roberts EJ, Hardjojo A, Carter V, Melle MV, Price D; Platform C19 committee. Stanley B, et al. PLoS One. 2021 Oct 19;16(10):e0258689. doi: 10.1371/journal.pone.0258689. eCollection 2021. PLoS One. 2021. PMID: 34665843 Free PMC article.
474 results